Searchable abstracts of presentations at key conferences in endocrinology

ea0032p603 | Female reproduction | ECE2013

PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenemia

Mastorakos George , Paltoglou George , Tavernarakis George , Christopoulos Panagiotis , Vlassi Margarita , Gazouli Maria , Deligeoroglou Efthimios , Creatsas George

Objective: To investigate the frequencies of three paraoxonase (PON)1 polymorphisms in Greek polycystic ovary syndrome (PCOS) and non-PCOS women, and their genotypes in association with hyperandrogenemia and insulin resistance.Design: Case–control genetic association study.Patients: PCOS cases (NIH criteria) and 112 controls.Main outcome measure: Genotyping of the c.−108C>T (PON1-108), the c.16...

ea0035p820 | Paediatric endocrinology | ECE2014

Anti-oxidation improves in early puberty in normal weight and obese boys, in positive association with exercise stimulated GH secretion

Paltoglou George , Fatouros Ioannis , Valsamakis George , Shina Maria , Avloniti Alexandra , Chantzinikolaou Athanasios , Kambas Antonis , Draganidis Dimitris , Mantzou Aimilia , Papagianni Maria , Kanaka-Gantenbein Christina , Chrousos George , Mastorakos George

Oxidative stress in humans has been associated with obesity. Puberty is a maturation period characterized mainly by changes of the GH and the gonadotrophin hormones secretion. To investigate the possible association of the GH and the hypothalamic–pituitary–gonadal (HPG) axes before and during early puberty, with the pro- and anti-oxidation mechanisms 76 healthy, pre-pubertal normal weight (n=28), pre-pubertal obese (n=11), early pubertal normal weig...

ea0058p009 | Bone | BSPED2018

A case of persistent hypercalcaemia, following accidental denosumab administration

Paltoglou George , Brain Caroline , Amin Rakesh , Durani Sina , Rajamoorthy Vidhooshni , Esther Freeman , Braha Nirit , De Keyser Paul , Calder Alistair , Allgrove Jeremy

Introduction: Denosumab, a human monoclonal antibody that inhibits activation of osteoclasts provides sustained suppression of bone turnover in osteolytic bone disease. Denosumab has rarely been associated with late hypercalcaemia following therapeutic administration for bone tumours in children, bone metastases in adults and in children with Osteogenesis Imperfecta Type VI.Case report: A male child of Indian origin was referred for advice to GOSH from a...